Iradimed (IRMD) Interest Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Interest Expenses data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 782.04% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 782.04% increase from a year earlier, with the FY2025 full-year figure at $144000.0, down 72.22% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.3 million, up from $144000.0 in the prior quarter.
• Over the last five years, Interest Expenses for IRMD reached as high as $1.3 million in Q1 2026 and fell as low as $30165.0 in Q2 2023.
• Historically, Interest Expenses has averaged $349735.7 across 5 years, with a median of $144000.0 in 2025.
• Across the five-year window, Interest Expenses sank 96.38% in 2022 and surged 782.04% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $492643.0 in 2022, then increased by 10.24% to $543099.0 in 2023, then sank by 92.86% to $38787.0 in 2024, then jumped by 271.26% to $144000.0 in 2025, then surged by 797.92% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $1.3 million in Q1 2026, $144000.0 in Q4 2025, and $1.0 million in Q3 2025.